Investors in SomaLogic have decided to approve a deal with Standard BioTools through a vote.

SomaLogic, a leading proteomics technology company, announced that its stockholders have voted to approve a transaction with Standard BioTools, a provider of life sciences tools. This approval represents a significant milestone towards the completion of the transaction, which aims to create a diversified leader in the life sciences tools sector. The combined company will benefit from enhanced scale and a stronger balance sheet to fuel future growth.

January 04, 2024
15 Articles

Further Reading